As much as TAVR's popularity has grown in recent years, there are still many instances when a heart team may find that surgery offers the best path forward. 

The recommendations were developed by a writing group comprised of experts from different specialties, offering an array of perspectives and approaches.

Sahil Parikh, MD, talked to Cardiovascular Business about growing trends related to the treatment of critical lower limb ischemia. "We are getting better and better at saving their limbs, but we are not better at saving their lives," he said. 

Read our monthly recap of FDA-related news items from the world of cardiovascular medicine. 

Here are links to more information on every late-breaking presentation at ACC.23.

Monthly marijuana use, meanwhile, was not associated with a greater CAD risk. The full study is scheduled to be presented at ACC.23/WCC in New Orleans.

According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications. 

“It's all about risks and benefits," one researcher said. "Starting transitioning is a big part of a person's life and helping them feel more themselves, but hormone replacement therapy also has a lot of side effects—it's not a risk-free endeavor."

The study, to be presented March 5 at ACC.23/WCC in New Orleans, examined outcomes data from 1999 to 2020. 

Prior chest imaging can sometimes be just as predictive of adverse events after surgery as updated imaging, according to new data set to be presented at the annual conference of the American College of Cardiology on March 5.